| Line 5: | Line 5: | ||
''ELISA-like assay''<BR> | ''ELISA-like assay''<BR> | ||
-Beginning of the ELISA-like assay (for nanoparticles characterization). | -Beginning of the ELISA-like assay (for nanoparticles characterization). | ||
| + | <BR><BR> | ||
<font size = "4"> Human practice </font> <BR> | <font size = "4"> Human practice </font> <BR> | ||
''Kit'' <BR> | ''Kit'' <BR> | ||
| - | - Remaking competent cells and transformation | + | - Remaking the same competent cells and transformation according to the BioBuilder protocol. |
- Starting the transformation with NEB 5-alpha competent cells. | - Starting the transformation with NEB 5-alpha competent cells. | ||
{{Template:EPFL2013Footer}} | {{Template:EPFL2013Footer}} | ||
Nanoparticles
ELISA-like assay
-Beginning of the ELISA-like assay (for nanoparticles characterization).
Human practice
Kit
- Remaking the same competent cells and transformation according to the BioBuilder protocol.
- Starting the transformation with NEB 5-alpha competent cells.
"
